Mix it with cold water or juice if desired
A tailored DNA nanoplatform for synergistic RNAi-/chemotherapy of multidrug-resistant tumors
Challenges and Limitations Research and Evidence Limitations Multiple challenges continue to constrain the current understanding of the therapeutic potential of BPC-157 and TB-500
To view a copy of this licence, visit About this article Cite this article Jos, S., Shivanandaswamy, N., Sharma, A
Bondonno CP, et al
has demonstrated that in case of cervical cancer, miR-1468-5p, a cancer-secreted exosome-encapsulated miRNA, promotes lymphatic PD-L1 upregulation and lymphangiogenesis, ultimately resulting in the impairment of lymphocyte T function